IP Library Granted Patent US 8,927,699
Granted Patent B2
US 8,927,699 · App. 10/590,810 · Granted Jan 6, 2015

Methods for obtaining thermostable enzymes, DNA polymerase I variants from

Inventors: Jean-Luc Jestin (Paris, FR); Sophie Vichier-Guerre (Gif sur Yvette, FR); Stephane Ferris (Mennecy, FR)
Assignees: Institut Pasteur; Centre National de la Recherche Scientifique (CNRS)
C07K14/43563C12N9/1252A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,699
App. No.
10/590,810
Granted
Jan 6, 2015
Kind
B2
Abstract

A thermostable mutant DNA polymerase; a method for obtaining the thernmostable mutant DNA polymerase by identifying a thermostable mutant polypeptide exhibiting enzymatic activity, wherein the thermostable mutant polypeptide is a variant of DNA polymerase I obtained from Thermus aquaticus ; a polynucleotide, an expression vector, and a host cell encoding the thermostable mutant DNA polymerase; and a method of performing a reverse transcription polymerase chain reaction (RT-PCR) utilizing the thermostable mutant DNA polymerase, as well as a kit for facilitating the same.

Claims (19)

1. An isolated or purified polynucleotide that encodes a polypeptide having at least 95% identity to residues 13-555 of SEQ ID NO: 26 and contains a mutation at position W550 of SEQ ID NO: 26, wherein said polypeptide has DNA polymerase activity, and

wherein said polypeptide comprises at least one other mutation within residues 13-555 of SEQ ID NO: 26.

2. The isolated or purified polynucleotide of claim 1 that has at least one mutation at an amino acid residue between residue 461 to 490 of SEQ ID NO: 26.

3. The isolated or purified polynucleotide of claim 1 , wherein said polypeptide has at least one mutation in amino acids 461 to 490 of SEQ ID NO: 26, or at a position selected from the group consisting of H203, F205, T232, E253, Q257, D274, L275, I276, V309, I322, A331, L332, D333, Y334, S335, I361, R374, A384, T387, Y419, P493, M498, G499, M502, L503, V506, R518, A523, A526, P539, and E543.

4. The isolated or purified polynucleotide of claim 1 that encodes a polypeptide having at least one mutation selected from the group consisting of A331T, S335N, M470K, M470R, F472Y, M484V, M484T, R518, and W550R.

5. The isolated or purified polynucleotide of claim 1 , wherein said polypeptide has at least 97.5% identity to residues 13-555 of SEQ ID NO: 26.

6. The isolated or purified polynucleotide of claim 1 that encodes an amino acid sequence selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 36, and SEQ ID NO: 38.

7. The purified polynucleotide of claim 1 that encodes a polypeptide that has a mutation at R518.

8. The isolated or purified polynucleotide of claim 7 that encodes a polypeptide that has a mutation R518G.

9. The isolated or purified polynucleotide of claim 1 that encodes a polypeptide that has at least one mutation selected from the group consisting of H203R, F205L, T232S, E253G, Q257R, D274G, L275H, L275P, I276F, V309I, I322N, A331V, S335N, I361F, R374Q, A384T, T387A, Y419C, Y419N, E465K, M470K, M470R, F472Y, F472S, A487T, K490E, P493T, M498T, G499E, M502K, L503P, V506I, R518G, A523V, A526V, P539S, E543K, and W550R.

10. The isolated or purified polynucleotide of claim 9 that encodes a polypeptide that comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 63, SEQ ID NO: 65, SEQ ID NO: 67, SEQ ID NO: 69, SEQ ID NO: 71, SEQ ID NO: 73, SEQ ID NO: 75, SEQ ID NO: 77, SEQ ID NO: 79, SEQ ID NO: 81, SEQ ID NO: 83, SEQ ID NO: 85, SEQ ID NO: 87, SEQ ID NO: 89, SEQ ID NO: 91, SEQ ID NO: 93, SEQ ID NO: 95, SEQ ID NO: 97, and SEQ ID NO: 99.

11. The isolated or purified polynucleotide of claim 1 that comprises a sequence selected from the group consisting of SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31, SEQ ID NO: 33, SEQ ID NO: 35, and SEQ ID NO: 37.

12. The isolated or purified polynucleotide of claim 1 that comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 62, SEQ ID NO: 64, SEQ ID NO: 66, SEQ ID NO: 68, SEQ ID NO: 70, SEQ ID NO: 72, SEQ ID NO: 74, SEQ ID NO: 76, SEQ ID NO: 78, SEQ ID NO: 80, SEQ ID NO: 82, SEQ ID NO: 84, SEQ ID NO: 86, SEQ ID NO: 88, SEQ ID NO: 90, SEQ ID NO: 92, SEQ ID NO: 94, SEQ ID NO: 96, and SEQ ID NO: 98.

13. An isolated or purified polynucleotide that is fully complementary to the polynucleotide of claim 1 .

14. A vector comprising the isolated or purified polynucleotide of claim 1 .

15. The vector of claim 14 , wherein said polynucleotide is operably linked to a heterologous expression sequence.

16. A host cell comprising the isolated or purified polynucleotide of claim 1 .

17. The isolated or purified polynucleotide of claim 1 that encodes a polypeptide comprising residues 13-555 of SEQ ID NO: 26 except that it contains a mutation at position W550 of SEQ ID NO: 26 that replaces tryptophan (W) with another amino acid residue.

18. The isolated or purified polynucleotide of claim 1 that encodes a polypeptide comprising residues 13-555 of SEQ ID NO: 26 except that it contains a mutation at position W550 of SEQ ID NO: 26 that replaces tryptophan (W) with an arginine (R) residue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2008
From: JESTIN, JEAN-LUC; VICHIER-GUERRE, SOPHIE; FERRIS, STEPHANE
To: INSTITUT PASTEUR; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Reel/Frame 020641/0009 →
Continuity (2)
Continuation In Part 10787219 · Feb 27, 2004
Related Publication 20080014609A1 · Jan 17, 2008